aibio
Debt Financing ·
Cynata takes $600,000 loan secured against R&D TI rebate
The $600,000 loan is secured against an expected R&D tax rebate of approximately $1.7m and the company's assets, and falls due by 30 September 2026 unless extended.
CYP Cynata Therapeutics Limited
Cynata Therapeutics (CYP) news
Latest Cynata Therapeutics news
We have not published a story on Cynata Therapeutics yet. When there is news, it will appear here.
Questions about Cynata Therapeutics
What is the ticker symbol of Cynata Therapeutics?
Cynata Therapeutics Limited trades under the ticker CYP on ASX.
Where is Cynata Therapeutics listed?
Cynata Therapeutics Limited is listed on ASX. Our directory also records these other listings: OTC:CYYNF.
Which country or territory is Cynata Therapeutics listed under?
Our directory records Cynata Therapeutics Limited under Australia.
What does Cynata Therapeutics do?
Our directory classifies Cynata Therapeutics Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Cynata Therapeutics?
The ISIN recorded for Cynata Therapeutics Limited is AU000000CYP7.
Does aibio.space cover Cynata Therapeutics?
aibio.space lists Cynata Therapeutics Limited among 2,820 public biotech companies and publishes its news here as stories appear.
What is the latest Cynata Therapeutics (CYP) stock news?
Our latest story on Cynata Therapeutics, dated Jul 6, 2026: "Cynata takes $600,000 loan secured against R&D TI rebate". The $600,000 loan is secured against an expected R&D tax rebate of approximately $1.7m and the company's assets, and falls due by 30 September 2026 unless extended. Source.
Does Cynata Therapeutics have debt, a term loan or convertible notes?
Our latest debt story, dated Jul 6, 2026: "Cynata takes $600,000 loan secured against R&D TI rebate". The $600,000 loan is secured against an expected R&D tax rebate of approximately $1.7m and the company's assets, and falls due by 30 September 2026 unless extended. Source.
How long will Cynata Therapeutics's cash last?
From our story of Jul 6, 2026: The company says its forecast cash runway now extends beyond the end of the 2027 financial year. Source.
Which companies are similar to Cynata Therapeutics?
Companies in our directory listed in the same country and business area as Cynata Therapeutics: Neuroscientific Biopharmaceuticals, Terragen Holdings, Imugene, Biotron, Kazia Therapeutics, Prescient Therapeutics.
How can I follow Cynata Therapeutics (CYP) news?
Press Follow on this page to add Cynata Therapeutics to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Cynata Therapeutics so far, in Debt Financing.
Investor discussion: Cynata Therapeutics
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Cynata Therapeutics Limited
- Ticker
- CYP
- Listing
- ASX
- Country or territory
- Australia
- Business scope
- Biotechnology
- ISIN
- AU000000CYP7
- Other listed symbols
- OTC:CYYNF
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction